HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mi-Ran Lee Selected Research

Arachidonate 5-Lipoxygenase (5 Lipoxygenase)

9/2010Anti-atherogenic effect of BHB-TZD having inhibitory activities on cyclooxygenase and 5-lipoxygenase in hyperlipidemic mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mi-Ran Lee Research Topics

Disease

7Atherosclerosis
06/2020 - 03/2010
3Neoplasms (Cancer)
11/2020 - 01/2006
2Obesity
06/2020 - 04/2009
2Atherosclerotic Plaque (Atheroma)
11/2014 - 03/2010
2Hyperlipidemias (Hyperlipidemia)
07/2014 - 09/2009
2Inflammation (Inflammations)
01/2014 - 02/2013
2Fatty Liver
09/2009 - 04/2009
2Hepatocellular Carcinoma (Hepatoma)
01/2006 - 11/2005
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020
1Body Weight (Weight, Body)
06/2020
1Metabolic Diseases (Metabolic Disease)
06/2020
1Necrosis
11/2014
1Cardiovascular Diseases (Cardiovascular Disease)
02/2013
1Vascular Remodeling
09/2011
1Neoplasm Metastasis (Metastasis)
03/2010
1Hypoxia (Hypoxemia)
03/2010
1Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2009
1Fibrosis (Cirrhosis)
09/2009

Drug/Important Bio-Agent (IBA)

4ApolipoproteinsIBA
07/2014 - 03/2010
3LDL Receptors (LDL Receptor)IBA
06/2020 - 03/2010
3Proteins (Proteins, Gene)FDA Link
01/2014 - 09/2009
2LipidsIBA
06/2020 - 04/2009
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
11/2014 - 03/2010
2ResistinIBA
07/2014 - 01/2014
2AlbuminsIBA
01/2006 - 11/2005
1Peptide Nucleic AcidsIBA
11/2020
1Tyrosine Kinase InhibitorsIBA
11/2020
1ErbB Receptors (EGF Receptor)IBA
11/2020
1Insulin-Like Growth Factor I (IGF-1)IBA
06/2020
1CollagenIBA
11/2014
1AdipokinesIBA
07/2014
1Lipoproteins (Lipoprotein)IBA
07/2014
1VLDL LipoproteinsIBA
07/2014
1CholesterolIBA
07/2014
1OvalbuminIBA
01/2014
1AntibodiesIBA
02/2013
1Monoclonal AntibodiesIBA
02/2013
1Apolipoproteins E (ApoE)IBA
02/2013
1Cell Adhesion MoleculesIBA
02/2013
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
02/2013
1Peroxidase (Myeloperoxidase)IBA
09/2011
1PeroxiredoxinsIBA
09/2011
1CatalaseIBA
09/2011
1Glutathione Peroxidase GPX1IBA
09/2011
1Sulfhydryl Compounds (Thiols)IBA
09/2011
1thiazolidine-2,4-dioneIBA
08/2011
1licofeloneIBA
09/2010
1Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
09/2010
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
09/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2010
1Hypoxia-Inducible Factor 1IBA
03/2010
1Interferon-gamma (Interferon, gamma)IBA
03/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2010
1CytokinesIBA
03/2010
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
03/2010
14-1BB Ligand (4 1BB Ligand)IBA
03/2010
1Plasminogen Activator Inhibitor 1IBA
09/2009
1Transforming Growth Factor beta (TGF-beta)IBA
09/2009
1Plasminogen InactivatorsIBA
09/2009
1PPAR alphaIBA
09/2009
1Choline (Choline Chloride)IBA
09/2009
1Methionine (L-Methionine)FDA Link
09/2009
1Pharmaceutical PreparationsIBA
09/2009
1Messenger RNA (mRNA)IBA
09/2009
1Fenofibrate (CiL)FDA LinkGeneric
09/2009
1BerberineIBA
04/2009
12'-benzoyloxycinnamaldehydeIBA
01/2006
1cinnamaldehyde (cinnamic aldehyde)FDA Link
01/2006

Therapy/Procedure

1Therapeutics
02/2013